HOME >> MEDICINE >> NEWS
AMPAKINE compounds a new potential treatment for respiratory depression

Drug-induced respiratory depression is a life-threatening condition caused by analgesic, hypnotic, and anesthesia medications. Although it is a leading cause of death from the overdose of some classes of abused drugs, respiratory depression also arises during normal, physician-supervised procedures such as surgical anesthesia, post-operative analgesia, and as a result of normal out-patient management of pain from cancer, accidents, or illnesses.

The majority of adverse events occurring with these drugs take place during the dose adjustment period, when two or more central nervous depressants are taken together, or when patients take prescribed drugs in ways not intended by their physician.

Although only 0.5%-1.2% of total adverse drug events caused by prescription medications are respiratory in nature, these serious side effects account for 25%-30% of drug-induced deaths. Opiates and barbiturates are the primary drugs classes responsible for these effects. Opiates include the standard pain-killing drugs morphine, fentanyl, and codeine, as well as related products vicodin, hydrocodone, and oxycontin. Barbituates comprise the sedative drugs amobarbital, aprobarbital, butabarbital, pentobarbital, and others. Sleeping disorders are another common predisposing factor for respiratory depression, in this case known as sleep apnea.

Currently, the only way to counter opiate-induced respiratory depression is to administer opiate receptor antagonists, drugs that block the effectiveness of opiate analgesia. While this approach may prevent a serious side effect or even death, it dramatically reduces the effectiveness of drugs administered for management of severe pain.

Researchers at the University of Alberta (Edmonton, AB) and Cortex Pharmaceuticals (Irvine, CA) believe that AMPAKINE drugs may provide protection from drug-induced respiratory depression, while simultaneously allowing the sedative or analgesic to continue working as it
'"/>

Contact: Mark Varney
mvarney@cortexpharm.com
949-231-0672
Cortex Pharmaceuticals
4-Jun-2007


Page: 1 2 3 4 5

Related medicine news :

1. New oxidation methods streamline synthesis of important compounds
2. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
3. U of M researchers discover compounds to shrink tumors
4. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
5. New compounds fight chronic symptoms of bowel disorders
6. New synthetic compounds appear to prevent brain cell death
7. Phenolic compounds may explain Mediterranean diet benefits
8. Vitamin D compounds show promise for prevention of prostate cancer
9. Hebrew University researcher develops compounds to control bacteria
10. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
11. Electric fields have potential as a cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... February 13, 2019 , ... American Vision ... in the nation, announced a new addition to their growing list of ophthalmology ... created within a multi-specialty ophthalmology practice. , Dr. Zachary Berbos, MD, ...
(Date:2/13/2019)... ... February 13, 2019 , ... Surgery that moves both jaws ... treatment for obstructive sleep apnea (OSA), resulting in benefits that include improved breathing, daytime ... a new study. , MMA should be regarded as the preferred treatment for patients ...
(Date:2/13/2019)... MONICA, Calif. (PRWEB) , ... February 13, 2019 ... ... of Southern California has joined the esteemed Haute Beauty network. , The ... privileged to present Dr. Christie as a leading Aesthetic surgeon and our newest ...
(Date:2/12/2019)... ... ... Attorney Harry Nelson , a leading expert on America’s healthcare future, a ... to donate $1-million from the online sales of his soon-to-be-released new book, The United ... America in 2019, according to Nelson. , Proceeds will be initially donated to ...
(Date:2/11/2019)... ... 11, 2019 , ... Z-Medica, LLC, a Linden Capital Partners ... appointment of nationally recognized cardiothoracic surgeon and researcher, Vinod Thourani, M.D., to the ... University School of Medicine and the Chairman of Cardiac Surgery for MedStar Heart ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... Wound Care ... Wound Care EHR software as an app inside their hospital’s EHR, substantially ... Wound Care EHR (electronic health record) pioneer, will soon launch its award-winning software ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... part of the Public Private Partnership (PPP) between the Department of Health-Abu Dhabi ... the region’s first Health Information Exchange system (HIE), a centralized platform to streamline ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... The Medicus ... of Staff Physician Recruiters (ASPR). “The Medicus Firm has been a vocal and ... Industry stewardship and support of educational programs are part of our DNA and ...
Breaking Medicine Technology:
Cached News: